Sar442168 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sar442168. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sar442168 Today - Breaking & Trending Today

Tolebrutinib Long-term Data Continue to Show the BTK Inhibitor Is Safe, Clinically Effective in MS

Tolebrutinib is an Bruton tyrosine kinase (BTK) inhibitor that is being investigated for use in patients who have relapsing multiple sclerosis (MS); investigators presented safety data from a long-term extension study of the phase 2b dose-finding trial.

....

United States , Wexlerm Tolebrutinib , University Of Toronto , American Academy Of Neurology , Barlo Multiple Sclerosis Program , American Academy , Expanded Disability Status Scale , Term Safety , Efficacy Study , Participants With Relapsing Multiple , Relapsing Multiple , Updated May , Btk Inhibitor ,